Spots Global Cancer Trial Database for female urogenital diseases

Every month we try and update this database with for female urogenital diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.	NCT05585476	Female Urogenit... Breast Cancer F...	C02 microablati... Regenerative to...	18 Years - 100 Years	Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab	NCT06237920	Urologic Neopla... Urogenital Neop... Neoplasms by Si... Neoplasms Female Urogenit... Female Urogenit... Urogenital Dise... Urinary Bladder... Male Urogenital... Urinary Bladder... Antineoplastics...	Nivolumab Relatlimab	18 Years -	The Netherlands Cancer Institute
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer	NCT03562897	Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan...	Ocoxin-Viusid	18 Years -	Catalysis SL
Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab	NCT06237920	Urologic Neopla... Urogenital Neop... Neoplasms by Si... Neoplasms Female Urogenit... Female Urogenit... Urogenital Dise... Urinary Bladder... Male Urogenital... Urinary Bladder... Antineoplastics...	Nivolumab Relatlimab	18 Years -	The Netherlands Cancer Institute
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer	NCT03562897	Carcinoma Ovarian Neoplas... Endocrine Gland... Urogenital Neop... Ovarian Disease... Adnexal Disease... Genital Disease... Female Urogenit... Female Urogenit... Endocrine Syste... Gonadal Disorde... Genital Neoplas... Neoplasms, Glan...	Ocoxin-Viusid	18 Years -	Catalysis SL
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC	NCT06114940	Neoplasms Kidney Neoplasm... Urologic Neopla... Urogenital Neop... Female Urogenit... Urogenital Dise... Kidney Diseases Urologic Diseas... Male Urogenital... Carcinoma Carcinoma, Rena... Antineoplastic ... Immune Checkpoi...	Toripalimab Lenvatinib	18 Years -	Jinling Hospital, China
Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC	NCT06114940	Neoplasms Kidney Neoplasm... Urologic Neopla... Urogenital Neop... Female Urogenit... Urogenital Dise... Kidney Diseases Urologic Diseas... Male Urogenital... Carcinoma Carcinoma, Rena... Antineoplastic ... Immune Checkpoi...	Toripalimab Lenvatinib	18 Years -	Jinling Hospital, China

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: